[[PAGE:1]]

EXPERT REVIEW

SME interpretation: the authorised product PFS benefit in EGFR-positive NSCLC is clinically relevant but must be communicated within approved boundaries without superiority overclaim.

[[PAGE:2]]

COMPARISON DISCIPLINE

Comparative statements require explicit label or CSR grounding. Avoid cure-adjacent language.